Clinical Trial Update: The Optical Coherence Tomography Drug Eluting Stent Investigation [NA]

View source ↗

Summary

A completed clinical trial evaluating an Optical Coherence Tomography-based drug-eluting stent for treating coronary artery disease. Sponsor is Boston Scientifi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Optical Coherence Tomography Drug Eluting Stent (drug-eluting stent)

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Coronary Artery Disease | NA | Status: COMPLETED